Cidara Therapeutics Inc. (NASDAQ: CDTX)
$23.5900
+0.3700 ( +3.01% ) 26.4K
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
Market Data
Open
$23.5900
Previous close
$23.2200
Volume
26.4K
Market cap
$245.58M
Day range
$22.0490 - $23.5690
52 week range
$10.0040 - $24.9900
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 19, 2024 |
4 | Insider transactions | 1 | Dec 19, 2024 |
4 | Insider transactions | 1 | Dec 19, 2024 |
4 | Insider transactions | 1 | Dec 19, 2024 |
4 | Insider transactions | 1 | Dec 19, 2024 |
4 | Insider transactions | 1 | Nov 29, 2024 |
8-k | 8K-related | 18 | Nov 26, 2024 |
8-k | 8K-related | 15 | Nov 07, 2024 |
10-q | Quarterly Reports | 71 | Nov 07, 2024 |
4 | Insider transactions | 1 | Oct 02, 2024 |